The concept of a meta-topical brainforest is proposed, to reflect a link between collaborative research and complex ecosystems. Tropical rainforests leverage a diversity of species to capture and convert solar energy into carbon-based life, and research teams can harvest a similar benefit from a diversity of data, tools, and thought paradigms.

According to the National Institutes of Health, team science is “a collaborative and often cross-disciplinary approach to scientific inquiry that draws researchers who otherwise work independently or as coinvestigators on smaller-scale projects into collaborative centers and groups” [1]. Thus, team science occurs when artificial boundaries such as departments and institutions are crossed, allowing collaboration in integrated networks. Over the past two decades, the concept has received increasing attention to better understand and address global challenges [2-5]. In 2007, Wuchty et al [6] examined 19.9 million research articles in the Institute for Scientific Information Web of Science database and 2.1 million patent records on multiple topics. They concluded that a team-authored paper has increased probability of being highly cited. The systems being formed through interdisciplinary collaborations help teams reach achievements that individual researchers are less likely to accomplish.

Kohane [7] pointed out that precision medicine in particular requires a higher level of coordination between various agencies and suggests the boundaries between research projects and clinical care institutions should be blurred to link gathered data. The exponential growth and causal interdependencies of “-omics” fields dictate that expertise across disciplines is essential to making meaningful and durable contributions to the understanding of human biology.

This brief viewpoint aims to explore the impact of cross-institution team science on the development of precision medicine. We hypothesized that international organizations with coleaders tend to publish more impactful papers than organizations without coleaders. Using the Pearson chi-square test and the Mann-Whitney U test, we validated our hypothesis.

Information was collected from the eHealth Catalogue of Activities developed by the nonprofit Global Alliance for Genomics and Health in 2015 [8]. The catalog lists international genomic and clinical data-sharing initiatives, and the eHealth Task Team updated the catalog through 2017. The data on the executive leadership team and publications were obtained from the websites of these organizations. If such information was not found, additional data were acquired by directly contacting the organizations or searching on Google Scholar. The impact of papers was evaluated by their number of citations, a criterion of research quality [6].

In this paper, coleadership means that a person holds a leadership position in different organizations concurrently. If two papers from separate organizations have at least one author in common, these two organizations are regarded as having a coauthor relationship.

Nonparametric tests were performed to verify the hypothesis. We used SPSS (version 22.0; IBM Corp) and R to perform two-tailed tests with an α level of .05. The significance of the correlation between the nominal variables coleadership and coauthorship was examined using the Pearson chi-square test of independence and expressed in a contingency table. The Pearson chi-square test of goodness of fit was adopted to evaluate whether organizations with coleaders had a greater number of publications than organizations without coleaders, and the Mann-Whitney U test was used to examine whether the former organizations published papers that received more citations than the latter.

We studied how precision medicine can be influenced by institutional-level team science by analyzing coleadership and coauthorship across health organizations. From 2015 to 2017, the number of health organizations grew from 69 to 87, and their publications increased. Concurrent positions held by leaders may incentivize researchers to work for multiple organizations; thus, the researchers will be very likely to have a coauthored paper (P<.001, both 2015 and 2017). Moreover, the publications from organizations with coleaders are more frequently cited, indicating a relatively high quality (Z=–13.547, P<.001). These results suggest that collaborations among health institutions are becoming stronger, which promotes their working efficiency.

These results illustrate the concept of meta-topical brainforests in precision medicine (Figures 1-2) and may have broader implications: cross-enterprise cooperation plays an essential role in solving complex issues. As a field-crossing example, Sovacool [9] suggested researchers should incorporate expertise and data from indigenous groups to address global environmental challenges.

One hopes the analogy persists and the extraordinary natural future-proofing mechanisms in rainforests coincide with similar continued diversification in research networks and widely impactful publications.